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olter Electrocardiogram
arameters in Risk
tratification of Arrhythmic
vents in Idiopathic
ilated Cardiomyopathy
ore Studies Are Needed*
ojciech Zareba, MD, PHD, FACC
ochester, New York
ecent advancements in the management of patients with
cute coronary syndromes and chronic coronary artery
isease have contributed to a decreasing number of ischemic
atients developing advanced left ventricular dysfunction
nd heart failure. Trends in clinical practices using device
herapy in patients with heart failure and left ventricular
ysfunction indicate that the incidence of nonischemic or
diopathic dilated cardiomyopathy (DCM) is increasing.
See page 225
urrent guidelines for the primary prevention of cardiac
ortality with implantable cardioverter-defibrillators
ICDs) in DCM patients are based on the landmark
EFINITE (Defibrillators in Non-Ischemic Cardiomyop-
thy Treatment Evaluation) trial (1) and the SCD-HeFT
Sudden Cardiac Death in Heart Failure Trial) (1,2). The
EFINITE trial enrolled DCM patients with ejection
raction 35% and a history of symptomatic heart failure
nd the presence of ambient arrhythmias (1). The SCD-
eFT (2) used low ejection fraction and presence of
ymptomatic heart failure (New York Heart Association
NYHA] functional class II or III) as entry criteria. Both
rials showed a marked improvement in survival with ICD
herapy; however, in both trials the majority of patients
even those assigned to conventional therapy) remained
symptomatic during follow-up. This high proportion
f patients without cardiac events raises the question of
hether we are able to identify high- and low-risk subsets of
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.o
From the Cardiology Division, University of Rochester Medical Center, Rochester,
ew York.atients with DCM to optimize ICD and other therapies.
owever, effective and clinically useful risk stratification in
CM patients remains a challenge. Low ejection fraction
nd advanced NYHA functional class are proven as impor-
ant risk factors, but they seem too unspecific for identifying
atients at risk for arrhythmic events. Moreover, preserved
eft ventricular function is increasingly seen in heart failure
atients, and there are no data regarding risk stratification in
hat population.
In this issue of the Journal, Iacoviello et al. (3) described
comprehensive risk-stratification study aiming to identify
linical and electrocardiogram (ECG) parameters that could
e useful in the risk stratification for arrhythmic events in
atients with idiopathic DCM. The main study population
onsisted of 179 patients with DCM and left ventricular
jection fraction of 34  10% (42% of patients had ejection
raction 35%). During 39  22 months follow-up, there
ere 24 arrhythmic events identified, including 9 sudden
eaths. There were a total of 15 deaths, regardless of causes.
oth mortality rates and arrhythmic event rates were rela-
ively low in the studied population, most likely due to a
igh proportion of patients with relatively preserved ejection
raction and possibly due to the relatively young age of
tudied patients: 49 years on average.
In comparison, the DEFINITE trial enrolled patients
ith mean ejection fraction of 31% and mean age of 58
ears (1). Despite these relatively low overall rates of cardiac
vents reported by Iacoviello et al. (3), the authors demon-
trated that within studied population there is a cohort of
atients at significantly increased risk of arrhythmic events.
his cohort could be identified by adding electrocardio-
raphic parameters to standard risk stratification based on
jection fraction dichotomized at 35%.
Detection of nonsustained ventricular tachycardia
NSVT) on Holter recordings (hazard ratio [HR] 2.96, p
.022) significantly improved risk stratification in patients
tudied by Iacoviello et al. (3). In the study by Iacoviello et
l. (3), NSVT was found in over 30% of patients, similar to
ates observed by Grimm et al. (4) in 343 patients from the
arburg Cardiomyopathy study. However, in the Grimm
t al. (4) study, NSVT on Holter was associated with only
trend toward higher arrhythmia risk (HR 1.7, p  0.11),
espite the fact that clinical characteristics of these 2 studied
opulations were quite similar. Another recent study by
aker and Koelling (5) in 355 DCM patients showed that
SVT was associated with decreased survival (HR 1.63, p
0.02). Zecchin et al. (6) evaluated 554 DCM patients
ith much longer follow-up of 81 months on average, and
ound that the presence or absence of NSVT at baseline did
ot differentiate patients with versus without cardiac events.
owever, they demonstrated that the presence of frequent
SVT episodes (3 runs/day) was associated with an
ncreased risk for total mortality (HR 1.68, p  0.041) and
ajor ventricular arrhythmias (HR 2.11, p  0.037), but
nly in the subgroup of patients with severe left ventricular
i
t
f
p
r
e
T
o
w
a
t
s
p
i
f
l
e
d
c
a
a
s
F
p
b
I
f
d
t
p
f
b
a
c
m
s
l
o
e
p
t
Q
w
r
v
s
a
l
p
i
E
i
i
t
R
R
R
e
r
R
1
1
1
233JACC Vol. 50, No. 3, 2007 Zareba
July 17, 2007:232–3 Editorial Commentmpairment. Therefore, a controversy still exists regarding
he prognostic significance of NSVT in DCM patients, and
urther studies are needed to document this association in
atients with well-documented arrhythmic events by inter-
ogated implantable devices.
Another important contribution of the study by Iacoviello
t al. (3) is the analysis of QT/RR slopes in DCM patients.
his is the first study evaluating the prognostic significance
f QT dynamics in DCM population. The QT/RR slope
as found to be predictive for arrhythmic events after
djustment for clinical covariates and presence of NSVT in
he model. Patients with arrhythmic events had significantly
teeper QT/RR slope in comparison with arrhythmia-free
atients. Increased QT/RR slope (0.19) was able to
dentify high-risk subset of DCM patients with ejection
raction 35%. Patients with low ejection fraction but with
ess steep slope (QT/RR slope 0.19) had much lower
vent rates. These findings indicate that evaluating QT
ynamics might provide clinically useful information when
onsidering ICD therapy. The observations by Iacoviello et
l. (3) correspond to a similar analysis conducted by Chev-
lier et al. (7) in postinfarction patients, where increased
lope (0.18) also identified a high-risk subset of patients.
acilitation of re-entry by shortening of the refractory
eriod might be considered as a potential mechanism
ehind this phenomenon (8).
Patients with ejection fraction 35% in the study by
acoviello et al. (3) were few in number and experienced very
ew events. As a result, there was limited statistical power to
etermine the prognostic usefulness of studied ECG parame-
ers in this subgroup of patients. It is possible that DCM
atients with relatively preserved ejection fraction might benefit
rom ECG-based risk stratification and optimization of therapy,
ut no studies have addressed this group of patients so far.
The study by Iacoviello et al. (3) also provides insight into
comprehensive approach for risk stratification combining
linical, echocardiographic, ECG, and Holter-based para-
eters. This approach reflects clinical practice and utilizes
tandard and broadly accessible technologies. We have
earned from this study that QRS duration, QTc duration,
r heart rate variability was not predictive for arrhythmic
vents in studied DCM patients. Instead, the authors
ropose a risk-stratification algorithm based on a combina-
ion of 3 parameters: low ejection fraction, NSVT, and
T/RR slope, each reflecting different mechanistic path-
ays that could lead to arrhythmic events. This algorithm
equires further testing in prospective cohorts to enable
alidation of the concept.
It is worth stressing that there are several other risk-
tratification methods utilizing the ECG including T-wave
lternans (9), QT variability (10,11), and heart rate turbu-
1ence (12,13). A direct comparison of these methods may
rovide us with clinically useful information to further
mprove clinical management of DCM patients. These
CG methods will, in the future, be complemented by
maging techniques like magnetic resonance imaging, allow-
ng a more precise assessment of myocardial changes and
heir propensity for major cardiac events.
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